<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180826040862N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-01-07</date_registration>
      <primary_sponsor>Qazvin University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Sex Counseling on Sexual Satisfaction in Women with Cyclic breast pain</public_title>
      <acronym></acronym>
      <scientific_title>Sexual Satisfaction after Psychosexual Counselling in Women with Cyclic Mastalgia: An Intervention Study based on the PLISSIT Model</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/33492</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Supportive, Other design features: This study consists of two groups witch one group receiving the intervention, Randomization description: The assignment of women with cyclic mastalgia into groups of intervention and control follows the method of simple randomization. According to this method, in each treatment center, a pool with letters of either A or B  kept within sealed envelopes will be considered. The number of envelopes matches the number of subjects in the study. Envelopes will be drawn from the pool without replacement by each subject who enters the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cyclic Mastalgia, Sexual Satisfaction.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: First, questionnaires will be completed by patients. This then will be followed by four one to one in-person counselling sessions. Sessions take place on a weekly basis and each lasts for 90 minutes. According to the PLISSIT model, sessions are summarised as follows: Session 1: Patient administration. During this session, the history of breast pain and sexual discomforts of the patient will be recorded.Session 2: Patient will receive a brief anatomical and physiological summary of limbs and breast.Session 3: Explicit recommendations. At this session, consultation on specific concerns such as fundamental sexual related concepts and training on specific sexual attitudes and practices and various forms of sexual stimulation will be provided.  Mental health screening will also be conducted at this session.Session 4: Referral for comprehensive treatment: After a careful evaluation of the patient's performance during the previous meetings, the patient will be referred if it was concluded that she requires more specialist psychosexual counselling in areas such as male sexual dysfunctions and psychological disorders.Patients will be asked to fill the questionnaires after the intervention completion and also three months after the final counselling session. Intervention 2: Control group: First, patients are asked to complete the questionnaire. Patients in this group will receive the current standard treatment for Mastalgia. The investigator will not provide the routine treatment. After completing counselling sessions for the intervention group, the control group will be asked to complete the questionnaire simultaneously.If the PLISSIT method outperforms the current standard treatment, after finishing the study, for ethical considerations, patients in the control group will also be introduced to the psychosexual counselling sessions by the investigator.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data from questionnaires is able to be shared (without the names of the samples).

When:
Six months after the publication of the results in the official journals

To whom:
All researchers working in educational and industrial institutions can apply for it.

Conditions:
If our documentation prevents repetition of a similar study.
If our documentation makes progress in a research process.

Where to obtain:
The main implementer of the project: Fatemeh Ghodsi
Address: unit 27, Ofogh 8 Building, 10th alley, Ferdowsi Avenue, Sadoghi Avenue
Tell:00989338678004
email: F.ghodsi@qums.ac.ir , fatimaghodsi@gmail.com

How to obtain:
It is necessary for the applicant to provide a complete introduction of his or her identity and to explain clearly why his request is necessary. After consultation with other administrators, in particular the supervisor, the requested files will be sent.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Ghodsi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>unit 27, Ofogh 8 Building, 10th alley, Ferdowsi Avenue, Sadoghi Avenue</address>
        <city>Qom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3716888976</zip>
        <telephone>+98 25 3293 5402</telephone>
        <email>F.ghodsi@qums.ac.ir</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Ghodsi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>unit 27, Ofogh 8 Building, 10th alley, Ferdowsi Avenue, Sadoghi Avenue</address>
        <city>Qom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3716888976</zip>
        <telephone>+98 25 3293 5402</telephone>
        <email>F.ghodsi@qums.ac.ir</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Breast pain of four or above based on the visual analogue scale pain which lasts more than five days according to the Cardiff Breast Clinic.
At least 20 years old
Having regular menstrual periods
Being Married and having regular sex
No menopause</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>55 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>pregnancy
Lactation
Having physical or mental illness (self-declaration)
Family or personal history of breast cancer
Drug Administration for treating breast pain in the last three months
Using hormonal methods for contraception</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N64.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Mastodynia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: First, questionnaires will be completed by patients. This then will be followed by four one to one in-person counselling sessions. Sessions take place on a weekly basis and each lasts for 90 minutes. According to the PLISSIT model, sessions are summarised as follows: Session 1: Patient administration. During this session, the history of breast pain and sexual discomforts of the patient will be recorded.Session 2: Patient will receive a brief anatomical and physiological summary of limbs and breast.Session 3: Explicit recommendations. At this session, consultation on specific concerns such as fundamental sexual related concepts and training on specific sexual attitudes and practices and various forms of sexual stimulation will be provided.  Mental health screening will also be conducted at this session.Session 4: Referral for comprehensive treatment: After a careful evaluation of the patient's performance during the previous meetings, the patient will be referred if it was concluded that she requires more specialist psychosexual counselling in areas such as male sexual dysfunctions and psychological disorders.Patients will be asked to fill the questionnaires after the intervention completion and also three months after the final counselling session.</i_keyword>
      <i_keyword>Control group: First, patients are asked to complete the questionnaire. Patients in this group will receive the current standard treatment for Mastalgia. The investigator will not provide the routine treatment. After completing counselling sessions for the intervention group, the control group will be asked to complete the questionnaire simultaneously.If the PLISSIT method outperforms the current standard treatment, after finishing the study, for ethical considerations, patients in the control group will also be introduced to the psychosexual counselling sessions by the investigator.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sexual satisfaction. Timepoint: Before the intervention - one  month after the intervention - three months after the intervention. Method of measurement: Larson Sexual Satisfaction Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Sex Distress. Timepoint: Before the intervention- one month after the intervention - three months after the intervention. Method of measurement: Sexual Distress Dissolved Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Qazvin University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-09-25</approval_date>
        <contact_name>Ethics committee of qazvin University of Medical Sciences</contact_name>
        <contact_address>Shahid Bahonar Blvd Qazvin Qazvin Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
